Latest Breaking News On - Society of immunology - Page 1 : comparemela.com

VC SKUAST-Jammu gets Life Time Achievement Award

VC SKUAST-Jammu gets Life Time Achievement Award
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

Jammu and kashmirNew delhiIndia generalSociety for immunologySociety of immunologyDepartment of animal husbandryMinistry of agriculture family welfareIcar national research centre on equinesInstitute of animal healthDepartment of biotechnologyAcademics societyNational action plans diseaseEnvironmental healthUniversity of agricultural sciences technology jammuCentre for vaccinesLife time achievement

Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting

Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaHong kongAsia pacificJay meiPeter qianAntengene corporationPrnewswire antengene corporation limitedMd anderson cancer centerDrug administrationCompany annualHong kong stock exchangeSociety of immunologyAntengene corporation limitedCorporation limitedCancer annual meetingInvestigational new drug

Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting

Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongSouth koreaSan diegoUnited statesPeter qianAsia pacificHong kong stock exchangeCompany annualSociety of immunologyAntengene corporationAntengene corporation limitedPrnewswire antengene corporation limitedCorporation limitedCancer annual meetingPatients beyondHong kong china

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

First Patient Dosed in Australia in ATG-101 First-in-Human Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaNew south walesKevin lynchCharlotte lemechAsia pacificAntengene corporationPrnewswire antengene corporation limitedScientia clinical researchAntengeneantengene corporation limited antengeneSociety of immunologyCorporation limitedChief medical officerMedical directorDose escalation phaseDose expansion phaseAntengeneantengene corporation limited

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Study to evaluate ATG-101, a proprietary PD-L1/4-1BB bispecific antibody Study will enroll patients with Metastatic/Advanced Solid Tumors and Mature B-Cell Non-Hodgkin Lymphomas SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced.

South koreaNew south walesKevin lynchCharlotte lemechAsia pacificPeter qianPrnewswire antengene corporation limitedScientia clinical researchAntengene corporation limitedSociety of immunologyAdvanced solid tumorsMatureb cell non hodgkinCorporation limitedChief medical officerMedical directorDose escalation phase